Integrated Diagnostics Holdings PLC
LSE:IDHC

Watchlist Manager
Integrated Diagnostics Holdings PLC Logo
Integrated Diagnostics Holdings PLC
LSE:IDHC
Watchlist
Price: 0.3955 USD 4.08% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
Integrated Diagnostics Holdings PLC?
Write Note

Net Margin
Integrated Diagnostics Holdings PLC

17.2%
Current
19%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
817.3m
/
Revenue
4.7B

Net Margin Across Competitors

Country JE
Market Cap 237.3m USD
Net Margin
17%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Net Margin
6%
No Stocks Found

Integrated Diagnostics Holdings PLC
Glance View

Market Cap
237.3m USD
Industry
Health Care

Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).

IDHC Intrinsic Value
0.5669 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
817.3m
/
Revenue
4.7B
What is the Net Margin of Integrated Diagnostics Holdings PLC?

Based on Integrated Diagnostics Holdings PLC's most recent financial statements, the company has Net Margin of 17.2%.